Back to search results

Psilocybin Therapy for Psychological Distress in Palliative Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

COPD (Chronic Obstructive Pulmonary Disease) · ALS (Amyotrophic Lateral Sclerosis) · MS (Multiple Sclerosis) · Major Depressive Disorder (MDD) · Atypical Parkinson Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • National Institute of Mental Health, Prague, Czechia

    Contact: Study coordinator (Tomas Palenicek) · tomas.palenicek@nudz.cz
    Contact: Principal Investigator (Tomas Palenicek)

  • Bispebjerg Hospital, Copenhagen, Denmark

    Contact: Study coordinator (Kirsten Svenstrup) · kirsten.svenstrup@regionh.dk
    Contact: Principal Investigator (Kirsten Svenstrup)
    Dea Siggaard Stenbaek (Sub-investigator)

  • University Medical Center Groningen, Groningen, Provincie Groningen, Netherlands

    Contact: Study coordinator (Robert Schoevers) · r.a.schoevers@umcg.nl
    Contact: Principal Investigator (Sanne Smith-Apeldoorn)
    Jeanine Kamphuis (Sub-investigator)

  • Champalimaud Foundation, Lisbon, Portugal

    Contact: Study coordinator (Albino Oliveira-Maia) · albino.maia@neuro.fchampalimaud.org
    Contact: Principal Investigator (Albino Oliveira-Maia)
    Carolina Seybert (Sub-investigator)
View source on ClinicalTrials.gov(opens in a new tab)